Abstract GS4-02: E2112: Randomized phase 3 trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer. A trial of the ECOG-ACRIN cancer research group
Year: 2021
Type: conference-abstract
Source: Cancer Research
Authors: Roisin M Connolly, Fengmin Zhao, Kathy D Miller, Min-Jung Lee, Richard L Piekarz, Karen L Smith, Ursa Brown-Glaberman, Jennifer S Winn, Bryan A Faller, Adedayo A Onitilo, Mark E Burkard, George T Budd, Ellis G Levine, Melanie E Royce, Peter A Kaufman, Alexandra Thomas, Jane B Trepel, Antonio C Wolff, Joseph A Sparano
Institutions: University College Cork, Dana-Farber Cancer Institute, Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, National Cancer Institute, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, University of New Mexico, New Mexico Cancer Center, UNM Comprehensive Cancer Center, Fox Chase Cancer Center, Missouri Baptist Medical Center, Marshfield Clinic, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Cleveland Clinic, Roswell Park Comprehensive Cancer Center, University of Vermont, University of Vermont Medical Center, Wake Forest University, Montefiore Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4205331091